Found 16 results
Filters: Keyword is DNA-Binding Proteins  [Clear All Filters]
2023
Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL et al..  2023.  Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines.. Sci Adv. 9(16):eade1282.
2018
Verma N, Pan H, Doré LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, González F, Krivtsov A, Chang C-J et al..  2018.  TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells.. Nat Genet. 50(1):83-95.
Chi J, Wu Z, Choi CHee J, Nguyen L, Tegegne S, Ackerman SE, Crane A, Marchildon F, Tessier-Lavigne M, Cohen P.  2018.  Three-Dimensional Adipose Tissue Imaging Reveals Regional Variation in Beige Fat Biogenesis and PRDM16-Dependent Sympathetic Neurite Density.. Cell Metab. 27(1):226-236.e3.
2017
Spehalski E, Capper KM, Smith CJ, Morgan MJ, Dinkelmann M, Buis J, Sekiguchi JAM, Ferguson DO.  2017.  MRE11 Promotes Tumorigenesis by Facilitating Resistance to Oncogene-Induced Replication Stress.. Cancer Res. 77(19):5327-5338.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M et al..  2017.  Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.. Nature. 546(7658):431-435.
Qi W, Gutierrez GE, Gao X, Dixon H, McDonough JA, Marini AM, Fisher AL.  2017.  The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins.. Aging Cell. 16(5):1125-1135.
2016
Tiwari MKaushik, Adaku N, Peart N, Rogers FA.  2016.  Triplex structures induce DNA double strand breaks via replication fork collapse in NER deficient cells.. Nucleic Acids Res. 44(16):7742-54.
2015
Jones M, Chase J, Brinkmeier M, Xu J, Weinberg DN, Schira J, Friedman A, Malek S, Grembecka J, Cierpicki T et al..  2015.  Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.. J Clin Invest. 125(5):2007-20.
Van Laarhoven PM, Neitzel LR, Quintana AM, Geiger EA, Zackai EH, Clouthier DE, Artinger KB, Ming JE, Shaikh TH.  2015.  Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.. Hum Mol Genet. 24(15):4443-53.
2014
Murphy AK, Fitzgerald M, Ro T, Kim JHyun, Rabinowitsch AI, Chowdhury D, Schildkraut CL, Borowiec JA.  2014.  Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery.. J Cell Biol. 206(4):493-507.
Kim H-J, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM-Y, Finkbeiner S, Gitler AD, Bonini NM.  2014.  Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.. Nat Genet. 46(2):152-60.
2013
McKenney ASophia, Levine RL.  2013.  Isocitrate dehydrogenase mutations in leukemia.. J Clin Invest. 123(9):3672-7.
2012
Argaw ATadesse, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG et al..  2012.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.. J Clin Invest. 122(7):2454-68.
Chung YRock, Schatoff E, Abdel-Wahab O.  2012.  Epigenetic alterations in hematopoietic malignancies.. Int J Hematol. 96(4):413-27.
1990
Simon MC, Rooney RJ, Fisch TM, Heintz N, Nevins JR.  1990.  E1A-dependent trans-activation of the c-fos promoter requires the TATAA sequence.. Proc Natl Acad Sci U S A. 87(2):513-7.